This steady pharmacologic presence contributed to participants achieving up to 24% body weight reduction over 48 weeks, representing some of the most substantial results observed in obesity pharmacotherapy
Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and fatty acid biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence
The structure is what gives the peptide its specific function, and aggressive handling can physically damage that structurea process called denaturation
Peptide drugs generally cost more than small molecule medications due to more complex manufacturing processes and lower production volumes
Excessive production of ROS not only directly damages cellular membranes, proteins, and DNA, but also activates inflammatory signaling pathways such as NF-B, thereby promoting the release of pro-inflammatory cytokines including TNF-, IL-1, and IL-6
Other conditions such as diabetes, autoimmune disorders, infections, and mechanical nerve compression can also produce similar symptoms
